Akari Therapeutics

0.90
-0.04 (-3.95%)
At close: Mar 04, 2025, 11:48 AM

Akari Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
PE Ratio -0.00 -0.00 -0.00 -0.00 -0.00 -0.01 -0.02 -0.05 -0.03 -0.01 -0.01 -0.01 -0.01 -0.03
PEG Ratio 0.00 0.00 0.00 0.00 -0.00 0.00 -0.00 0.00 0.00 0.00 -0.00 0.00 -0.00 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio -0.03 0.01 0.01 0.00 0.00 0.02 0.03 0.02 0.03 0.02 0.01 -0.01 -0.01 n/a
P/FCF Ratio -0.00 -0.00 -0.00 -0.00 -0.00 -0.01 -0.02 -0.03 -0.25 -0.01 -0.01 -0.01 -0.02 -0.06
P/OCF Ratio -0.00 -0.00 -0.00 -0.00 -0.00 -0.01 -0.02 -0.03 -0.25 -0.01 -0.01 -0.01 -0.02 -0.06
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.00 -0.27 n/a n/a
Quick Ratio 0.95 1.35 1.91 3.47 2.07 5.98 3.19 3.90 3.30 4.73 6.36 0.29 0.01 n/a
Current Ratio 0.95 1.15 1.91 3.37 1.88 5.33 3.19 3.90 3.30 4.73 6.36 0.29 0.01 n/a
Asset Turnover n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a n/a -2.98 -10.01 n/a -17.85 -3.52 n/a -158.4
Return on Equity (ROE) 43.70 -3.89 -3.17 -1.42 -5.67 -1.49 -1.4 -0.53 -0.93 -1.99 -0.62 0.43 0.85 n/a
Return on Assets (ROA) -2.3 -0.5 -1.51 -1 -2.11 -1.21 -0.96 -0.4 -0.65 -1.49 -0.46 -1.28 -78.48 n/a
Return on Capital (ROIC) 73.39 -12.89 -3.1 -1.45 -5.13 -1.49 -1.75 -0.8 -0.63 -1.99 -0.55 1.34 1.02 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a